Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?

Authors

DOI:

https://doi.org/10.33448/rsd-v10i10.18817

Keywords:

ABO system; COVID-19; Antigen.

Abstract

Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored.

References

Breiman, A., Ruvën-Clouet, N. & Le Pendu, J. (2020). Aproveitando a resposta imune anti-glicano natural para limitar a transmissão de vírus com envelope, como o SARS-CoV-2. PLoS Pathog, 16 (1), 1-4. https://doi.org/10.1371/journal.ppat.1008556

Brunner, S. H. (2000). Chemical and Biochemical Basis of Antigen Specificity. 2th ed.springer Wien New York.

Castro, M. L. B., Carvalho, M. H., Locatelli, M. F. & Bordin, S. (2000). Molecular heterogeneity of the A3 subgroup. Clin. Lab. Haem. 22 (1), 73-78.

Cheng, Y., Cheng, G. & Chui, C. H. (2005). Grupo sanguíneo ABO e suscetibilidade à síndrome respiratória aguda grave. JAMA. 2005; 293 (23), 1450-1451. https://doi.org/10.1001/jama.293.12.1450-c

Dzik, S., Eliason, K., Morris, E. B., Kaufman, R. M. & North, C. M. (2020). COVID-19 e grupos sanguíneos ABO. Transfusion, 60 (8), 1883-1884. https://doi.org/10.1111/trf.15946

Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., Fernández, J., Prati, D., Baselli, G. & Asselta, R. (2020). Estudo da Genomewide Association of Severe Covid-19 com Parada respiratoria. New England Journal of Medicine. 383 (16), 1522-1534.

Fan, H., Zhang, L., Huang, B., Zhu, M., Zhou, Y. & Zhang, H. (2020). Retrospective analysis of clinical features in 101 death cases with COVID-19. MedRxiv. Preprint. 1-31. https://doi.org/10.1101/2020.03.09.20033068

Geraldo, A. & Martinello, F. (2020). A relação entre o sistema sanguíneo ABO e a COVID-19: uma revisão sistemática. Universidade Federal de Santa Catarina (UFSC). Florianópolis-SC, Brasil, 369-370.

Gérard, C., Maggipinto, G. & Minon, J. M. (2020). Covid-19 e grupo sanguíneo ABO: outro ponto de vista. British Journal of Hematology. 190 (2), 93-94. https://doi.org/10.1111/bjh.16884

Lee, A. H. & Reid, M. E. (2000). ABO blood group system: a review of molecular aspects. Immunohematology, 16 (1), 1-6.

Li, J., Wang, X., Chen, J., Cai, Y., Deng, A. & Yang, H. (2020). Associação entre grupos sanguíneos ABO e risco de pneumonia por SARS-CoV-2. Br J Haematol. 190 (1), 14-27. https://doi.org/10.1111/bjh.16797.

Machado, B. A., Wagner, A. G., Carlotto, F. M., Santos, M. M. P. D., Nunes, E. G., Wink, C. M., Martins, F. T., Dagostini, L. B. & Araújo, C. S. R. (2020). Análise dos grupos sanguíneos ABO e RH em pacientes com Covid-19 que necessitaram de transfusão sanguínea. Hematol Tranfus Cell Ther. 42 (2), 380. https://doi.org/10.1016/j.htct.2020.10.639

Olsson, M. L. & Chester, M. A. (2001). Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies. Transfusion Medicine. 11(4), 295-313.

Padhi, S., Suvankar, S., Dash, D., Panda, V. K, Pati, A., Panigrahi, J., & Panda, A. K (2020). O sistema de grupo sanguíneo ABO está associado à mortalidade por COVID-19: Uma investigação epidemiológica na população indiana. Transfusion Clinique et Biologique. 27 (4), 253-258.

Plenge, R. M. (2020). Molecular Underpinnings of Severe Coronavirus Disease 2019. JAMA, 324 (7), 638-639.

Rodrigues, R. L., Roberti, M. D. R. F., Santos, A. P. A., Souza, L. M., Gonçalves, A. V., Amorelli, M. C. R. & Candido, F. B. (2020). M. Relação entre grupos sanguíneos e a Covid-19. Hematol Tranfus Cell Ther. 42 (1), 552-553.

Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A.T. & Veesler, D. (2020). Structure, Function e Antigenicidade da glicoproteína de pico SARS-CoV-2. Cell. 181 (2), 281-292.

Wu, B.B., Gu, D. Z., Yu, J. N., Yang, J., & Chen, H. L. (2020). Associação entre grupos sanguíneos ABO e infecção, gravidade e morte por COVID-19: uma revisão sistemática e meta-análise. Infection, Genetics and Evolution. 84 (104485).

Yamamoto, F. & Hakomori, S. (1990). Sugar-nucleotide donor specificity of histo-blood group A and B transferase is based on amino acid substitutions. J. Biol. Chem. 265 (1), 19257-19262.

Yaylaci, S. & Koroglu, M. (2020). The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Rev. Assoc. Med. Bras. 66 (2). https://doi.org/10.1590/1806-9282.66.S2.86

Yoshida, A., Yamaguchi, Y. D. & Dave, V. (1979). Immunologic homology of human blood group glycosyltransferases and genetic background of blood group (ABO) determination. Blood. 59 (1), 344-350.

Zaidi, Z., Zaidi, A. R. Z., Abdullah, S. M. & Zaidi, S. Z. A. (2020). Covid-19 e a conexão do grupo sanguíneo ABO. Transfusion and Apheresis Science. 59 (5), 1-3. https://doi.org/10.1016/j.transci.2020.102838

Zeitz, M. & Tatonetti N. P. (2020). Testando a associação entre tipo de sangue e infecção por COVID-19, intubação e morte. Nat Commun. 11 (1), 1-6. https://doi.org/10.1038/s41467-020-19623-x

Zeng, X., Fan, H., Lu, D., Huang, F., Meng, X. & Li, Z. (2020). Association between ABO blood groups and clinical outcome of coronavirus disease 2019: evidence from two cohorts. MedRxiv. Preprint. 1-27.

https://doi.org/10.1101/2020.04.15.20063107

Zhao, J., Yang, Y., Huang, F., Meng, X. & Li, Z. (2020). Relationship between the ABO blood group and the COVID-19 susceptibility. MedRxiv. Preprint. 1-18. https://doi.org/10.1101/2020.03.11.20031096

Downloads

Published

08/08/2021

How to Cite

SOUTO, B. O. V.; FIGUEIREDO, B. Q. de; SILVA, A. C. M.; COURY, B. F.; DURANTE, G. .; AMORIM, G. S.; SILVA, G. P. da .; MEDEIROS, G. A.; MIRANDA, L. D.; OLIVEIRA, N. S. S.; OLIVEIRA, R. C. Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?. Research, Society and Development, [S. l.], v. 10, n. 10, p. e188101018817, 2021. DOI: 10.33448/rsd-v10i10.18817. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/18817. Acesso em: 23 nov. 2024.

Issue

Vol. 10 No. 10

Section

Health Sciences

License

Copyright (c) 2021 Bárbara Oliveira Vasconcelos Souto; Bárbara Queiroz de Figueiredo; Andressa Caetano Martins Silva; Bruno Faria Coury; Gabriele Durante; Gardênia Silva Amorim; Gilvane Pereira da Silva; Gustavo Alves Medeiros; Luana Damaceno Miranda; Nicolly Skarlet Souto Oliveira; Rúbia Carla Oliveira

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.